| Literature DB >> 31237909 |
Nina Huynh1, Andrea Baumann1, Mark Loeb2,3,4.
Abstract
The objective of this study was to conduct a systematic analysis of the reporting quality of the Ebola Virus Disease (EVD) outbreak in West Africa from 2014-2018 using the Modified STROBE statement. We included studies on the 2014 EVD outbreak alone, limited to those on human patients in Africa. We searched the following databases (MEDLINE, EMBASE, and Web of Science) for outbreak reports published between 2014-2018. We assessed factors potentially associated with the quality of reporting. A total of 69 of 131 (53%) articles within the full-text review fulfilled our eligibility criteria and underwent the Modified STROBE assessment for analyzing the quality of reporting. The Modified STROBE scores of the included studies ranged from 11-26 points and the mean was found to be 19.54 out of 30 with a standard deviation (SD) of ± 4.30. The top three reported Modified STROBE components were descriptive characteristics of study participants, scientific background and evidence rational, and clinical significance of observations. More than 75% of the studies met a majority of the criteria in the Modified STROBE assessment tool. Information that was commonly missing included addressing potential source of bias, sensitivity analysis, further results/analysis such as risk estimates and odds ratios, presence of a flowchart, and addressing missing data. In multivariable analysis, peer-reviewed publication was the only predictor that remained significantly associated with a higher Modified STROBE score. In conclusion, the large range of Modified STROBE scores observed indicates variability in the quality of outbreak reports for EVD. The review identified strong reporting in some areas, whereas other areas are in need of improvement, in particular providing an important description of the outbreak setting and identifying any external elements (potential biases and confounding factors) that could hinder the credibility of the findings.Entities:
Mesh:
Year: 2019 PMID: 31237909 PMCID: PMC6592536 DOI: 10.1371/journal.pone.0218170
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow diagram of search strategy and outbreaks included based on eligibility criteria.
Components of the Modified STROBE checklist and proportion of articles (n = 69) accurately reporting each item [13].
| Modified STROBE Item | Component Description | n(%) Accurately Reported |
|---|---|---|
| A) Either title, abstract or both sections clearly indicated study design | 60(87) | |
| B) Study’s focus and investigation details within title, abstract or both sections (e.g. Ebola subtype, geographic location, setting) were clearly elicited | 64(93) | |
| C) Informative summary provided in the abstract discussing steps taken along with investigation findings | 52(75) | |
| A) Scientific background, evidence, rationale provided for reporting and conducting investigation | 67(97) | |
| B) Specific objectives for study stated, included pre-established hypothesis if applicable | 63(91) | |
| C) Specific quantiles provided: for example, number of outbreaks/communities reported, number of patients from Ebola outbreak (suspected, confirmed, total) | 69(100) | |
| D) A timeline of the study was provided: includes start/finish dates of conducted investigation or outbreak | 57(83) | |
| A) Present key elements of study design early in report | 59(86) | |
| B) Was decision to report promoted by any outcome data? | 63(91) | |
| C) Number of patients admitted during outbreak | 59(86) | |
| D) Distribution provided for patient demographics | 48(70) | |
| E) Proportion admitted from other hospitals, wards, communities | 32(46) | |
| F) Potential risk factors for acquiring organism included | 47(68) | |
| G) Case definitions for outbreaks were included | 48(70) | |
| H) Proportions of patient outcomes were included (e.g. ICU, hospitalization, mortality) | 58(84) | |
| I) Description of unit, hospital, community | 28(41) | |
| J) Provide eligibility criteria for selection of cases, participants and/or controls (more for cohort/case control) | 51(74) | |
| K) Provide number of exposed/unexposed (cohort) or controls per case (case-control) | 42(61) | |
| L) Describe any efforts to address potential sources of bias | 2(3) | |
| M) Explain how the final study size was arrived at (for patient/case count) | 30(43) | |
| N) Explain how missing data were addressed | 17(25) | |
| O) Describe any sensitivity analysis | 6(9) | |
| A) Consider use of a flow diagram to depict patient or participant count at each stage of investigation | 13(19) | |
| B) Descriptive characteristics of study participants (e.g. demographics, clinical, social) information on exposures and any other associative factors | 68(99) | |
| C) Timeline: chart to display duration of patient stay, date of detecting organisms | 59(86) | |
| D) Consideration of any confounding variables (e.g. use of antibiotics, length of stay changes) | 15(22) | |
| E) Further results and analysis: if applicable, provide unadjusted and confounder-adjusted estimates with confidence intervals(e.g. risk estimates, odds ratios) | 16(23) | |
| A) Clinical signification of observation was considered and hypotheses were reviewed in relation to the findings | 66(96) | |
| B) Discuss limitations of study, accounting for any potential bias | 38(55) | |
| C) Discussed generalizability (external validity) of findings and applicability with current evidence) | 52(75) |
Key components of the Modified STROBE checklist and proportion of articles (n = 69) accurately reporting each item.
| Modified STROBE Item | Component Description | n(%) Accurately Reported |
|---|---|---|
| 3A | Present key elements of study design early in report | 59(86) |
| 3G | Case definitions for outbreaks were included | 48(70) |
| 3J | Provide eligibility criteria for selection of cases, participants and/or controls (more for cohort/case-control) | 51(74) |
| 3L | Describe any efforts to address potential sources of bias | 2(3) |
| 4B | Give characteristics of study participants (e.g., demographic, clinical, social) + information on exposures and any other associative factors | 68(99) |
Univariate and multivariate analysis of predictors for reporting quality.
| Predictor Variables | Comparison Groups | n (%) | Modified STROBE Mean Score (SD) | Mean Difference (95% CI) | P-values (Univariate Analysis) | P- values (Multivariate regression model) |
|---|---|---|---|---|---|---|
| Publication Year | >2015 | 25(36) | 21.84(3.03) | 3.61(1.81 to 5.41) | <0.001 | 0.089 |
| ≤2015 | 44(64) | 18.22(4.40) | ||||
| Journal Type | Peer-reviewed | 46(67) | 21.48(3.29) | 5.83(4.13 to 7.52) | <0.001 | 0.001 |
| Epidemiologic Report | 23(33) | 15.65(3.41) | ||||
| Outbreak Setting | Hospital | 47(68) | 20.02(4.63) | 1.52(-0.69 to 3.73) | 0.174 | 0.812 |
| Community | 22(32) | 18.50(3.41) | ||||
| Author Affiliation | Academic Institution | 23(33) | 21.39(3.50) | 2.78(0.83 to 4.74) | 0.01 | 0.943 |
| Non-academic Institution | 46(67) | 18.61(4.41) |
Cl (confidence intervals); SD (standard deviation)